The Jett Foundation Fighting Duchenne Muscular Dystrophy

Jett Foundation/FDA Approval news

September 28, 2016

On September 19, 2016, the FDA granted accelerated approval for eteplirsen, making it the first approved therapy for Duchenne muscular dystrophy.  This historic approval has been the focus of many news items, below are some news coverage that highlights Jett Foundation’s advocacy efforts and impact.

Published September 24, 2016
For one mother bittersweet victory, long sought drug finally approved

christinejettbridgewater

http://https://www.bostonglobe.com/business/2016/09/24/for-one-mother-bittersweet-victory-long-sought-drug-finally-approved/sJzi4oKTs8CDvEVzPE3xcI/story.html

______________________________________________________

Published September 19, 2016
Approval for Duchenne muscular dystrophy drug gives families hope

http://http://www.fox25boston.com/news/approval-for-duchenne-muscular-dystrophy-drug-giving-family-hope/447666826

______________________________________________________

Published on September 20, 2016

First muscular dystrophy drug Ok’ed by FDA
http://www.necn.com/on-air/as-seen-on/NECN_092016_Connolly_MS_Drug_5PM_NECN-394191051.html

______________________________________________________

 

 

Show Buttons
Hide Buttons